4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine
C18H19F2N7S — CID 155798953
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine
4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine (PubChem CID 155798953) has the molecular formula C18H19F2N7S and a molecular weight of 403.46 g/mol. Its IUPAC name is 4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine.
Molecular Properties
| Compound Name | 4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine |
|---|---|
| PubChem CID | 155798953 |
| Molecular Formula | C18H19F2N7S |
| Molecular Weight | 403.46 g/mol |
| Exact Mass | 403.14 |
| IUPAC Name | 4-[4-[6-(difluoromethyl)-2-methylsulfanylpyrimidin-4-yl]piperazin-1-yl]-2-methylpyrido[3,4-d]pyrimidine |
| SMILES | CSc1nc(C(F)F)cc(N2CCN(c3nc(C)nc4cnccc34)CC2)n1 |
| InChI | InChI=1S/C18H19F2N7S/c1-11-22-14-10-21-4-3-12(14)17(23-11)27-7-5-26(6-8-27)15-9-13(16(19)20)24-18(25-15)28-2/h3-4,9-10,16H,5-8H2,1-2H3 |
| InChIKey | RGYNDEAQXKMRFA-UHFFFAOYSA-N |
| XLogP | 3.11 |
| TPSA | 70.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 403.46 |
| LogP ≤ 5 | 3.11 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155798953 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.